Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

BACKGROUND: Although previous studies have evaluated the effect of anti-VEGF therapies for central retinal vein occlusion (CRVO) patients, the majority of previous studies have excluded or included a very small number of patients with ischemic CRVO (iCRVO). The aim of our study is to examine the eff...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Retina Vitreous
Prif Awduron: Hall, Leangelo, Frizzera, Luma Paiva, Coelho, Laura Fernandes, Carricondo, Pedro Carlos, Oyamada, Maria Kiyoko, Pimentel, Sergio Luis Gianotti, Abalem, Maria Fernanda
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2019
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6659291/
https://ncbi.nlm.nih.gov/pubmed/31372240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-019-0183-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg